Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsetib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Project: Research

Project Details

StatusFinished
Effective start/end date06/26/17 → 02/26/24

Funding

  • Gilead Sciences Incorporated: $158,508.00